US 2026 brings together senior leaders from across commercial, medical, market access, operations, and launch excellence to explore what it takes to deliver successful pharmaceutical launches in today ...

Lund, Sweden-based Hansa Biopharma AB has announced that the first commercial patient in Australia has received a living donor kidney transplant following treatment with Idefirix (imlifidase), ...

Sanofi is laying off 229 former Blueprint Medicines employees in Cambridge, MA and closing two legacy Blueprint facilities.

Blood disorder specialist Fulcrum Therapeutics has agreed to what amounts to a reverse merger with Slate Medicines, a ...

The pharma-adjacent tech and services sectors continued to attract experienced leadership talent during June and July, with ...

At this year’s NHS ConfedExpo, one message came through clearly: innovation is already improving care across the NHS, but we ...

DMD affects approximately 15,000 individuals in the United States and primarily impacts boys. Over time, deterioration of the ...

Lantheus Holdings, Inc., a Bedford, Massachusetts-headquartered radiopharmaceutical-focused company, announced on 14 th ...

England is on track to be one of the first countries in the world to eliminate the hepatitis C virus (HCV), thanks to a pioneering antiviral drugs programme. Since 2015, around 100,000 people have ...

Just a few weeks after filing for bankruptcy protection, Sangamo Therapeutics has found buyers for some of its key assets, including a Fabry disease therapy and its genomic medicine platforms. PTC ...

A therapy room used to deliver the one-off, therapist-assisted treatment. Psychedelic drug developer Definium Therapeutics has reported positive phase 3 results with its LSD-based therapy, DT120, in ...